4
Changes in Ownership
Immunocore Holdings plc Filed Acc 0001730038-26-000002
CHIEF EXECUTIVE OFFICER sold 11,474 shares at $32.35 ($371,184)
- CHIEF EXECUTIVE OFFICER acquired 23,817 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jallal Bahija · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-17 | Exercise or conversion : show line 1 in the form | +23,817 | 23,817 | D | ||
| 2026-02-18 | Sale : show line 2 in the form | −11,474 | $32.35 | $371,184 | 12,343 | D |
| Open-market sales · 11,474 sh · avg $32.35 · $371,184 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-17 | Exercise or conversion : show line 3 in the form Restricted Share Units | −23,817 | 71,453 | D |
| 2026-02-17 | Grant or award : show line 4 in the form Restricted Share Units | +88,573 | 88,573 | D |
| 2026-02-17 | Grant or award : show line 5 in the form Employee Share Option (Right to Buy) | +395,066 | 395,066 | D |
Loading xslF345X05/form4-02192026_050209.xml…